These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 33211437)
1. [Covid-19 and diabetes]. Paquot N; Radermecker RP Rev Med Liege; 2020 Sup; 75(S1):138-145. PubMed ID: 33211437 [TBL] [Abstract][Full Text] [Related]
2. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. Jornayvaz FR; Assouline B; Pugin J; Gariani K BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762 [TBL] [Abstract][Full Text] [Related]
3. COVID 19: Diabetes and Obesity API-ICP Recommendations. Joshi SR; Tiwaskar MH; Shah SN J Assoc Physicians India; 2020 May; 68(5):42-44. PubMed ID: 32610865 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review. Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543 [TBL] [Abstract][Full Text] [Related]
5. [The endocrine and metabolic link between COVID-19, diabetes and obesity]. Weis N; Thorsteinsson K; Martinussen C; Madsbad S Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864 [TBL] [Abstract][Full Text] [Related]
6. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. Hayden MR J Int Med Res; 2020 Jul; 48(7):300060520939746. PubMed ID: 32722979 [TBL] [Abstract][Full Text] [Related]
8. Glucovigilance in COVID-19. Lamptey R; Ahomagnon S; Acheampong F; Kalra S J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386 [TBL] [Abstract][Full Text] [Related]
9. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy. Mirani M; Favacchio G; Carrone F; Betella N; Biamonte E; Morenghi E; Mazziotti G; Lania AG Diabetes Care; 2020 Dec; 43(12):3042-3049. PubMed ID: 33023989 [TBL] [Abstract][Full Text] [Related]
10. [Severe COVID-19, a new complication to be added to numerous comorbidities associated to obesity]. De Flines J; Scheen AJ Rev Med Liege; 2020 Sup; 75(S1):146-152. PubMed ID: 33211438 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study. Soliman AT; Prabhakaran Nair A; Al Masalamani MS; De Sanctis V; Abu Khattab MA; Alsaud AE; Sasi S; Ali EA; Ola A H; Iqbal FM; Nashwan AJ; Fahad J; El Madhoun I; Yassin MA Acta Biomed; 2020 Sep; 91(3):e2020010. PubMed ID: 32921708 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115 [TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China. Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977 [No Abstract] [Full Text] [Related]
14. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598 [TBL] [Abstract][Full Text] [Related]
15. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019. Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119 [No Abstract] [Full Text] [Related]
16. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159 [TBL] [Abstract][Full Text] [Related]
17. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak. Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837 [TBL] [Abstract][Full Text] [Related]
18. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
19. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella. Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A Front Immunol; 2020; 11():1714. PubMed ID: 32793244 [TBL] [Abstract][Full Text] [Related]
20. Issues for the management of people with diabetes and COVID-19 in ICU. Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P; Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]